Therapeutic Potential of Fluoxetine in Neurological Disorders

The selective serotonin reuptake inhibitor (SSRI) fluoxetine, which is registered for a variety of psychiatric disorders, has been found to stimulate the cAMP‐responsive element binding protein (CREB), increase the production of brain‐derived neurotrophic factor (BNDF) and the neurotrophic peptide S...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:CNS Neurosci Ther
Huvudupphovsmän: Mostert, Jop P., Koch, Marcus W., Heerings, Marco, Heersema, Dorothea J., De Keyser, Jacques
Materialtyp: Artigo
Språk:Inglês
Publicerad: Blackwell Publishing Inc 2008
Ämnen:
Review
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC6494017/
https://ncbi.nlm.nih.gov/pubmed/18482027
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1527-3458.2008.00040.x
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk